Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
about
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeIntra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockIntra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockCoronary care medicine: it's not your father's CCU anymoreKinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data.Using systems biology to simplify complex disease: immune cartography.Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry.Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial infarction: preliminary data.The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysisFibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trialPrognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stressPredictors of outcome after percutaneous treatment for cardiogenic shockThe role of urine neutrophil gelatinase--associated lipocalin (NGAL) in acute heart failure in patients with ST--elevation myocardial infarction.The pathology of myocardial infarction in the pre- and post-interventional era.Postmortem diagnosis of acute myocardial infarction in patients with acute respiratory failure: demographics, etiologic and pulmonary histologic analysisLevosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational studyManagement of cardiogenic shock attributable to acute myocardial infarction in the reperfusion era.Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry.Middle cerebral artery resistivity and pulsatility indices in systemic lupus erythematosus: evidence for hyperperfusion.Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shockTiming, setting and incidence of cardiovascular complications in patients with acute myocardial infarction submitted to primary percutaneous coronary intervention.Percutaneous mechanical cardiac assist in myocardial infarction. Where are we now, where are we going?FGF-23 is associated with increased disease severity and early mortality in cardiogenic shockCardiogenic shock complicating myocardial infarction and outcome following percutaneous coronary intervention.Serious infection after acute myocardial infarction: incidence, clinical features, and outcomesBench-to-bedside review: nitric oxide in critical illness--update 2008.Nitric oxide synthase inhibitors in cardiogenic shock: present and future.ECMO in cardiac arrest and cardiogenic shockEmerging drugs for acute myocardial infarction.Cardiogenic shock: the role of inflammation.Coronary revascularization: 2011.Evaluation and management of shock States: hypovolemic, distributive, and cardiogenic shock.Staging of multivessel percutaneous coronary interventions: an expert consensus statement from the Society for Cardiovascular Angiography and Interventions.Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy.Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock--review of the current evidence.Translating metabolomics to cardiovascular biomarkers.Therapeutic strategies for high-dose vasopressor-dependent shock.
P2860
Q24201225-4680C810-AFBD-4D9B-B6BD-F56FA106BCA0Q24203783-101EB1D4-5E62-4D29-9909-94537AF3359FQ24235462-D1038669-AA9E-4099-8666-F2D56A0D62C9Q24242133-40BF061F-A6D7-443B-85FC-C9FAE93EA425Q28200986-13C1CD5E-C09A-4709-AACD-F3F696ED15FEQ33653520-F9A147D9-4A85-4013-B941-1F6A1B094D80Q33828840-419786EA-8BE6-4896-A110-5F1B4E4B608DQ34317141-A8DB58BA-D33A-4076-9FB4-B746C259959DQ34471018-D48EB42D-EB95-4BCB-BCB5-116204C33D92Q34601344-00ED3246-8B68-4981-B23B-335225AB1319Q34971810-F1955BFD-8775-497C-8076-4F945A605652Q35008805-E47B2884-7A28-4F3B-B739-CC6BE32B1105Q35422363-A0A025C4-3DDA-4050-ABB9-24657162C01FQ35583747-634AA1CA-2059-444E-A0F1-B0192B186C84Q35662587-DE6F0834-0B68-4331-BB3E-D13915A8575DQ35772556-3ABE468A-D382-4F7F-A117-7C155DA836CFQ35813407-E8C3BA26-0EB2-4090-B765-3CDB5CBBDC64Q36070389-607B1FA9-58C3-495A-969E-339110067BE3Q36215368-3E3FBC2D-04CE-4371-85E8-19435338A00DQ36227295-13A8CB2B-921C-45E7-B7D8-74E57B5DAEBFQ36507318-9E6D8E98-4E51-4FCD-94E3-842227A98796Q36739809-29ED672E-B5F9-4878-8268-194ED0989BDBQ36921063-0ACA9343-9066-4DCF-AF81-06F6BCBDA0CAQ36940572-65D1420B-6B0D-46D1-9F51-FBE61C72F682Q36966769-61BF6108-5A61-4FAF-B051-4437801BE31DQ37291894-14001F58-47E1-4F55-BA4E-4E5B0FC54DCBQ37313224-5CCEACF6-111E-444C-8E9A-90C6008E6ACDQ37442453-085DC6D0-3A21-4F0D-9A14-CFA01320A9E1Q37576051-2A05A8B0-236E-434D-9360-6EB077FFEE72Q37608590-99E62812-D512-4C1C-98C3-EDB6D669C5BAQ37639744-5AF4A4A0-8119-4727-8B91-82B7C1CC4453Q37670190-1F962B8C-EFA4-4BDE-AD6D-85FF58B030CFQ37805473-B0DD3E0B-8E97-49B6-AABB-BFB79EBD4773Q37862930-250A7719-66DC-46FE-9CB3-56B88D5ECC89Q37867315-27CAA6A1-F33C-4092-B8F1-007384D73C7CQ37954589-2D2BCA16-DDF7-4575-8315-0E96D5268113Q37969891-39FBB4D0-2C53-4FCD-AA68-A2AD93EB76C1Q38011221-5776F0F3-44F4-4707-B796-60AA38E7A17FQ38028672-1AF11198-0E38-4374-884B-2BCF1B625936Q38154892-05C3EF7A-B201-4CD4-9BB0-0EF036A6BD97
P2860
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
@ast
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
@en
type
label
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
@ast
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
@en
prefLabel
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
@ast
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
@en
P1433
P1476
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
@en
P2093
Judith S Hochman
P304
P356
10.1161/01.CIR.0000075927.67673.F2
P407
P577
2003-06-01T00:00:00Z